Lo, J. A., Fisher, D. E., & Flaherty, K. T. (2015). Prognostic significance of cutaneous adverse events associated with pembrolizumab therapy. JAMA Oncol.
Stile di citazione ChicagoLo, Jennifer A., David E. Fisher, e Keith T. Flaherty. "Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy." JAMA Oncol 2015.
Citazione MLALo, Jennifer A., David E. Fisher, e Keith T. Flaherty. "Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy." JAMA Oncol 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.